README.md

BLCAsubtyping

Transcriptomic tools to classify bladder tumours according to six published molecular classifications : Baylor[1], UNC[2], MDA[3], Lund[4], CIT-Curie[5], TCGA[6]

Citation

For now, you can cite the following bioRxiv preprint: bioRxiv 488460; doi: https://doi.org/10.1101/488460 https://github.com/cit-bioinfo/BLCAsubtyping

Consensus Class

For the Consensus BLCA classification, please use the consensusMIBC package: https://github.com/cit-bioinfo/consensusMIBC

Install

You may install this package with devtools:

require(devtools)
devtools::install_github("cit-bioinfo/BLCAsubtyping", build_vignettes = TRUE)

Documentation

After installation, please refer to the vignette or function help files by calling:

library(BLCAsubtyping)
vignette("BLCAsubtyping")
? classify

References

[1] Mo, Q. et al. Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas. J. Natl. Cancer Inst. (2018).

[2] Damrauer, J. S. et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc. Natl. Acad. Sci. U.S.A. 111, 3110–3115 (2014).

[3] Choi, W. et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25, 152–165 (2014).

[4] Marzouka, N. et al. A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort. Scientific Reports 8, 3737 (2018).

[5] Rebouissou, S. et al. EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype. Sci Transl Med 6, 244ra91 (2014).

[6] Robertson, A. G. et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 171, 540-556.e25 (2017).



cit-bioinfo/BLCAsubtyping documentation built on Dec. 31, 2022, 2:22 p.m.